• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质磷酸化失调:大脑衰老和阿尔茨海默病连续体中的决定性条件。

Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease.

机构信息

Department of Pathology and Experimental Therapeutics, University of Barcelona, Hospitalet de Llobregat, Spain.

CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Hospitalet de Llobregat, Spain.

出版信息

Brain Pathol. 2021 Nov;31(6):e12996. doi: 10.1111/bpa.12996. Epub 2021 Jul 4.

DOI:10.1111/bpa.12996
PMID:34218486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8549032/
Abstract

Tau hyperphosphorylation is the first step of neurofibrillary tangle (NFT) formation. In the present study, samples of the entorhinal cortex (EC) and frontal cortex area 8 (FC) of cases with NFT pathology classified as stages I-II, III-IV, and V-VI without comorbidities, and of middle-aged (MA) individuals with no NFT pathology, were analyzed by conventional label-free and SWATH-MS (sequential window acquisition of all theoretical fragment ion spectra mass spectrometry) to assess the (phospho)proteomes. The total number of identified dysregulated phosphoproteins was 214 in the EC, 65 of which were dysregulated at the first stages (I-II) of NFT pathology; 167 phosphoproteins were dysregulated in the FC, 81 of them at stages I-II of NFT pathology. A large percentage of dysregulated phosphoproteins were identified in the two regions and at different stages of NFT progression. The main group of dysregulated phosphoproteins was made up of components of the membranes, cytoskeleton, synapses, proteins linked to membrane transport and ion channels, and kinases. The present results show abnormal phosphorylation of proteins at the first stages of NFT pathology in the elderly (in individuals clinically considered representative of normal aging) and sporadic Alzheimer's disease (sAD). Dysregulated protein phosphorylation in the FC precedes the formation of NFTs and SPs. The most active period of dysregulated phosphorylation is at stages III-IV when a subpopulation of individuals might be clinically categorized as suffering from mild cognitive impairment which is a preceding determinant stage in the progression to dementia. Altered phosphorylation of selected proteins, carried out by activation of several kinases, may alter membrane and cytoskeletal functions, among them synaptic transmission and membrane/cytoskeleton signaling. Besides their implications in sAD, the present observations suggest a molecular substrate for "benign" cognitive deterioration in "normal" brain aging.

摘要

tau 过度磷酸化是神经原纤维缠结 (NFT) 形成的第一步。在本研究中,对无共病的 NFT 病理分类为 I-II 期、III-IV 期和 V-VI 期的额皮质 (EC) 和额前皮质 8 区 (FC) 以及无 NFT 病理的中年 (MA) 个体的 EC 和 FC 样本进行了分析,采用常规无标签和 SWATH-MS(顺序窗口采集所有理论片段离子谱质谱)来评估(磷酸化)蛋白质组。在 EC 中鉴定出 214 个失调磷酸化蛋白,其中 65 个在 NFT 病理的早期(I-II)阶段失调;在 FC 中鉴定出 167 个失调磷酸化蛋白,其中 81 个在 NFT 病理的 I-II 期失调。在两个区域和 NFT 进展的不同阶段,发现了大量失调的磷酸化蛋白。失调磷酸化蛋白的主要组成为膜、细胞骨架、突触、与膜转运和离子通道相关的蛋白质以及激酶的成分。本研究结果表明,在老年(在临床上被认为是正常衰老的个体)和散发性阿尔茨海默病(sAD)中,NFT 病理的早期阶段存在蛋白质异常磷酸化。FC 中蛋白磷酸化失调先于 NFT 和 SP 的形成。失调磷酸化最活跃的时期是在 III-IV 期,此时可能有一部分个体被临床归类为患有轻度认知障碍,这是向痴呆进展的前期决定阶段。一些激酶的激活改变了选定蛋白的磷酸化,可能会改变膜和细胞骨架的功能,其中包括突触传递和膜/细胞骨架信号转导。除了对 sAD 的影响外,本研究观察结果表明,在“正常”大脑衰老中,“良性”认知衰退有一个分子基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/c9eedf3704bd/BPA-31-e12996-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/4bee168d81a5/BPA-31-e12996-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/716e8f48a565/BPA-31-e12996-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/e45885bd39cd/BPA-31-e12996-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/a9654a0ed825/BPA-31-e12996-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/406319cf458f/BPA-31-e12996-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/1987578c9cb5/BPA-31-e12996-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/d05b2e6216ad/BPA-31-e12996-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/c9eedf3704bd/BPA-31-e12996-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/4bee168d81a5/BPA-31-e12996-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/716e8f48a565/BPA-31-e12996-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/e45885bd39cd/BPA-31-e12996-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/a9654a0ed825/BPA-31-e12996-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/406319cf458f/BPA-31-e12996-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/1987578c9cb5/BPA-31-e12996-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/d05b2e6216ad/BPA-31-e12996-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9526/8549032/c9eedf3704bd/BPA-31-e12996-g029.jpg

相似文献

1
Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease.蛋白质磷酸化失调:大脑衰老和阿尔茨海默病连续体中的决定性条件。
Brain Pathol. 2021 Nov;31(6):e12996. doi: 10.1111/bpa.12996. Epub 2021 Jul 4.
2
Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology.蛋白质磷酸化失调是神经原纤维缠结病理早期阶段颗粒空泡变性的主要促成因素。
Neuroscience. 2023 May 10;518:119-140. doi: 10.1016/j.neuroscience.2021.10.023. Epub 2021 Oct 30.
3
Proteostatic modulation in brain aging without associated Alzheimer's disease-and age-related neuropathological changes.脑老化而无相关阿尔茨海默病和年龄相关神经病理学变化的蛋白质稳态调节。
Aging (Albany NY). 2023 May 13;15(9):3295-3330. doi: 10.18632/aging.204698.
4
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.[F-18]-AV-1451 结合与死后神经纤维缠结 Braak 分期相关。
Acta Neuropathol. 2017 Oct;134(4):619-628. doi: 10.1007/s00401-017-1740-8. Epub 2017 Jun 13.
5
Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model.脑内蛋白质磷酸化失调与 hTau 转基因小鼠模型中人类 Tau 表达增加有关。
Int J Mol Sci. 2022 Jun 8;23(12):6427. doi: 10.3390/ijms23126427.
6
Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.tau 种子活性首先出现在(transentorhinal/entorhinal)区域,并且可预测阿尔茨海默病和 PART 中的磷酸化 tau 病理学。
Acta Neuropathol. 2018 Jul;136(1):57-67. doi: 10.1007/s00401-018-1855-6. Epub 2018 May 11.
7
A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.一种翻译后修饰特征定义了可溶性tau 的变化,这些变化与早期阿尔茨海默病大脑中的寡聚化相关。
Acta Neuropathol Commun. 2019 Dec 3;7(1):192. doi: 10.1186/s40478-019-0823-2.
8
Anatomic survey of seeding in Alzheimer's disease brains reveals unexpected patterns.阿尔茨海默病大脑中播散的解剖学研究揭示了意想不到的模式。
Acta Neuropathol Commun. 2021 Oct 11;9(1):164. doi: 10.1186/s40478-021-01255-x.
9
Hypothesis review: Alzheimer's overture guidelines.假设性综述:阿尔茨海默病前期指南
Brain Pathol. 2023 Jan;33(1):e13122. doi: 10.1111/bpa.13122. Epub 2022 Oct 12.
10
Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine.氧化损伤产物的组织化学积累与犬类的阿尔茨海默样病理相关。
Amyloid. 2004 Jun;11(2):90-100. doi: 10.1080/13506120412331285779.

引用本文的文献

1
Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis.全基因组测序揭示脂质途径和载脂蛋白E基因型对脑淀粉样变性的影响。
Hum Mol Genet. 2025 Apr 6;34(8):739-748. doi: 10.1093/hmg/ddaf017.
2
Synaptic phosphoproteome modifications and cortical circuit dysfunction are linked to the early-stage progression of alpha-synuclein aggregation.突触磷酸化蛋白质组修饰和皮质回路功能障碍与α-突触核蛋白聚集的早期进展有关。
bioRxiv. 2025 Jan 25:2025.01.24.634820. doi: 10.1101/2025.01.24.634820.
3
Degenerative Disease Diagnosis and Analysis Based on Tissue Specificity of DNA Methylation.

本文引用的文献

1
New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein.二酰基甘油激酶、磷酸脂酸和磷酸脂酸结合蛋白的新纪元。
Int J Mol Sci. 2020 Sep 16;21(18):6794. doi: 10.3390/ijms21186794.
2
Phosphorylated tau interactome in the human Alzheimer's disease brain.人类阿尔茨海默病大脑中磷酸化 tau 的相互作用组。
Brain. 2020 Sep 1;143(9):2803-2817. doi: 10.1093/brain/awaa223.
3
White matter alterations in Alzheimer's disease without concomitant pathologies.阿尔茨海默病患者无伴随病理的脑白质改变。
基于DNA甲基化组织特异性的退行性疾病诊断与分析
Int J Mol Sci. 2025 Jan 7;26(2):452. doi: 10.3390/ijms26020452.
4
Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial.帕金森病患者联合代谢激活剂治疗后认知功能改善的多组学特征:一项随机、双盲、安慰剂对照的II期试验。
Brain Commun. 2025 Jan 6;7(1):fcae478. doi: 10.1093/braincomms/fcae478. eCollection 2025.
5
Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging.淀粉样β蛋白病理学是灵长类大脑衰老的常见命名蛋白病变。
J Alzheimers Dis. 2024;100(s1):S153-S164. doi: 10.3233/JAD-240389.
6
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.PD-1/LAG-3 共信号通路分析揭示 CBL 泛素连接酶为免疫治疗的关键靶点。
EMBO Mol Med. 2024 Aug;16(8):1791-1816. doi: 10.1038/s44321-024-00098-y. Epub 2024 Jul 19.
7
Circulating small extracellular vesicles in Alzheimer's disease: a case-control study of neuro-inflammation and synaptic dysfunction.阿尔茨海默病中小细胞外囊泡的循环:神经炎症和突触功能障碍的病例对照研究。
BMC Med. 2024 Jun 20;22(1):254. doi: 10.1186/s12916-024-03475-z.
8
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.死亡相关蛋白激酶 1 作为阿尔茨海默病的治疗靶点。
Transl Neurodegener. 2024 Jan 9;13(1):4. doi: 10.1186/s40035-023-00395-5.
9
Sex-specific role of galectin-3 in aortic stenosis.半乳糖凝集素-3 在主动脉瓣狭窄中的性别特异性作用。
Biol Sex Differ. 2023 Oct 24;14(1):72. doi: 10.1186/s13293-023-00556-1.
10
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.阿尔茨海默病是人类大脑自然老化的固有组成部分:综合视角。
Free Neuropathol. 2022 Jul 8;3:17. doi: 10.17879/freeneuropathology-2022-3806. eCollection 2022 Jan.
Neuropathol Appl Neurobiol. 2020 Dec;46(7):654-672. doi: 10.1111/nan.12618. Epub 2020 May 1.
4
Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls.阿尔茨海默病患者与年龄匹配认知健康对照者脑的多重磷酸化蛋白质组学研究。
OMICS. 2020 Apr;24(4):216-227. doi: 10.1089/omi.2019.0191. Epub 2020 Mar 17.
5
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.深度多层脑蛋白质组学鉴定阿尔茨海默病进展中的分子网络。
Neuron. 2020 Mar 18;105(6):975-991.e7. doi: 10.1016/j.neuron.2019.12.015. Epub 2020 Jan 8.
6
Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts.作为一种膜紊乱疾病的阿尔茨海默病:β-淀粉样肽、烟碱型乙酰胆碱受体与脂筏之间的空间相互作用
Front Cell Neurosci. 2019 Jul 18;13:309. doi: 10.3389/fncel.2019.00309. eCollection 2019.
7
SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse.SynGO:一个基于证据的、专家编辑的突触知识库。
Neuron. 2019 Jul 17;103(2):217-234.e4. doi: 10.1016/j.neuron.2019.05.002. Epub 2019 Jun 3.
8
The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?阿尔茨海默病的新遗传图谱:从淀粉样蛋白级联到基因驱动的突触故障假说?
Acta Neuropathol. 2019 Aug;138(2):221-236. doi: 10.1007/s00401-019-02004-0. Epub 2019 Apr 13.
9
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
10
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease.原发性年龄相关性 tau 病(PART)和阿尔茨海默病的神经病理学、遗传学和纵向认知特征。
Alzheimers Dement. 2019 Jan;15(1):8-16. doi: 10.1016/j.jalz.2018.07.215. Epub 2018 Dec 11.